Replies to post #411 on Aratana Therapeutics Inc (fka PETX)

[BlueRayn]

Not confused at all. Subtract $3.7Mil to Elanco and you have $1.5Mil in the 2nd qtr of 2017. The same qtr of 2018 you have $4.9Mil. That is a big jump even if you add a hypothetical $1Mil in licensing payment to 2nd qtr of 2017 would take it only to $2.5Mil compared to the $4.9Mil now reported. Simple math